Altogether, these results strongly support that the downregulation of Trk signaling is instrumental in inhibiting the invasiveness of cSCC cells in vivo and disrupts the metastatic cascade in cSCC by modulating key pro-invasive pathways, including FAK and EMT markers. The gene discussed is NTRK1; the disease is skin squamous cell carcinoma.